DE
42
-3
APH
52
-4
DG
63
-2
BDX
57
-2
ADSK
59
-2
CAG
37
-3
D
38
-5
AMAT
49
-4
DOW
40
-2
AMZN
53
-4
CVS
41
-2
AVY
47
-4
VIX
49
6
CA
42
12
BMY
71
-3
CTAS
39
-3
APD
52
-3
DOV
63
-6
CINF
58
-2
DTE
40
-5
DE
42
-3
APH
52
-4
DG
63
-2
BDX
57
-2
ADSK
59
-2
CAG
37
-3
D
38
-5
AMAT
49
-4
DOW
40
-2
AMZN
53
-4
CVS
41
-2
AVY
47
-4
VIX
49
6
CA
42
12
BMY
71
-3
CTAS
39
-3
APD
52
-3
DOV
63
-6
CINF
58
-2
DTE
40
-5
Financhill
Back

Vertex Pharmaceuticals, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
48

VRTX
Vertex Pharmaceuticals, Inc.

Last Price:
$453.38
Seasonality Move:
0.02%
Sell
39

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.25
Seasonality Move:
-0.81%
Sell
48
Vertex Pharmaceuticals, Inc. (VRTX) is a Sell

Is Vertex Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $453.36. The Score for VRTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $36.31. The Score for ZBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals, Inc.'s stock price today?

  • The Vertex Pharmaceuticals, Inc. share price today is $453.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight selling pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $36.31
    The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 125.77 Buy
Relative Strength Index (14 RSI): 54.61 Buy
Chaikin Money Flow: -157875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (437.91 - 460.33) Buy
Bollinger Bands (100): (392.1 - 440.74) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.68 Buy
Relative Strength Index (14 RSI): 47.21 Sell
Chaikin Money Flow: 289999 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.8 - 41.14) Sell
Bollinger Bands (100): (19.01 - 36.29) Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 458.56 Sell
20-day SMA: 453.68 Sell
50-day SMA: 436.81 Buy
200-day SMA: 439.72 Buy
8-day EMA: 419.89 Buy
20-day EMA: 288.97 Buy
50-day EMA: 150.59 Buy
200-day EMA: 43.45 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.86 Sell
20-day SMA: 38.54 Sell
50-day SMA: 35.24 Buy
200-day SMA: 19.17 Buy
8-day EMA: 35.64 Buy
20-day EMA: 24.68 Buy
50-day EMA: 12.87 Buy
200-day EMA: 3.71 Buy

Vertex Pharmaceuticals, Inc. Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.79 per share, and an increase next year of $2.27 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.15 per share.

Vertex Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):